39 Results

People

  1. Kris
    Kris
  2. Seshan
    Seshan
  3. Miller
    Miller
  4. Riely
    Riely
  5. Rusch
    Rusch
  6. Azzoli
    Azzoli
  7. Krug
    Krug
  8. Shen
    Shen
  9. Rizvi
    Rizvi
  10. Bains
    Bains

Groups

  1. Biostatistics Service (39)
  2. Department of Medicine (39)
  3. Epidemiology and Biostatistics (39)
  4. Solid Tumor Oncology Division (39)
  5. Thoracic Oncology (39)
  6. Center for Pancreatic Cancer Research (17)
  7. Population Sciences Research Program (17)
  8. Surgery (15)
  9. Survivorship Research (14)
  10. GSK Faculty (12)
  1. "aged"
  2. "Biostatistics Service"
  3. "Mark Kris"
Formats
  1. Journal Article (38)
  2. Conference Paper (1)
Groups
  1. Biostatistics Service (39)
  2. Department of Medicine (39)
  3. Epidemiology and Biostatistics (39)
  4. Solid Tumor Oncology Division (39)
  5. Thoracic Oncology (39)
  6. Center for Pancreatic Cancer Research (17)

More Groups

People
  1. Mark Kris (39)
  2. Venkatraman Seshan (16)
  3. Gregory Riely (12)
  4. Valerie Rusch (12)
  5. Vincent Miller (12)
  6. Christopher Azzoli (10)

More People

Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (2)
  6. 2012 (2)

More Years

Publications
  1. Cancer (8)
  2. Clinical Cancer Research (6)
  3. Journal of Clinical Oncology (6)
  4. Journal of Thoracic Oncology (6)
  5. Annals of Thoracic Surgery (3)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. Elsevier Inc. (8)
  2. Wiley Blackwell (8)
  3. American Association for Cancer Research (6)
  4. American Society of Clinical Oncology (6)
  5. Elsevier Science, Inc. (4)
  6. Oxford University Press (2)

More Publishers

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save
  • The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: A retrospective study
    Journal Article

    Zauderer, M. G.; Martin, A.; Egger, J.; Rizvi, H.; Offin, M.; Rimner, A.; Adusumilli, P. S.; Rusch, V. W.; Kris, M. G.; Sauter, J. L.; more...
    The Lancet Digital Health (2021)

    Fulltext@MSK | Save
  • Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Journal Article

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
    Journal Article

    D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci
    Journal Article

    Krug, L. M.; Ragupathi, G.; Hood, C.; George, C.; Hong, F.; Shen, R.; Abrey, L.; Jennings, H. J.; Kris, M. G.; Livingston, P. O.
    Cancer Immunology, Immunotherapy (2012)

    Fulltext@MSK | Save
  • Contemporary results of surgical resection of non-small cell lung cancer after induction therapy: A review of 549 consecutive cases
    Journal Article

    Barnett, S. A.; Rusch, V. W.; Zheng, J.; Park, B. J.; Rizk, N. P.; Plourde, G.; Bains, M. S.; Downey, R. J.; Shen, R.; Kris, M. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save